Efficacy and Tolerability of DITROPAN XL (Oxybutynin Chloride) Versus DETROL LA (Tolterodine Tartrate) in Treatment of Overactive Bladder
Clinical trial NCT00293839 · COMPLETED
Trial details
- NCT number
- NCT00293839
- Sponsor
- Alza Corporation, DE, USA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 790
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.